Clinical Trial Update: Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating the combination of chemotherapy and imatinib mesylate in patients with extensive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Gleevec (imatinib) (imatinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED